ENTRY       D10191                      Drug
NAME        Safinamide mesylate (USAN);
            Safinamide mesilate (JAN);
            Safinamide methanesulfonate;
            Xadago (TN);
            Equfina (TN)
PRODUCT     XADAGO (MDD US Operations LLC)
FORMULA     C17H19FN2O2. CH4SO3
EXACT_MASS  398.1312
MOL_WEIGHT  398.449
CLASS       Neuropsychiatric agent
             DG01568  MAO inhibitor
              DG01512  Monoamine oxidase B inhibitor
             DG01967  Antiparkinson agent
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
             DG02917  MAO substrate
              DG03178  MAOA substrate
REMARK      Therapeutic category: 1169
            ATC code: N04BD03
            Chemical structure group: DG01260
            Product (DG01260): D10191<JP/US>
EFFICACY    Antiparkinsonian, Monoamine oxidase B (MAO-B) inhibitor
  DISEASE   Parkinson's disease [DS:H00057]
COMMENT     Treatment of Parkinson's disease
TARGET      MAOB [HSA:4129] [KO:K00274]
  PATHWAY   hsa04726(4129)  Serotonergic synapse
            hsa04728(4129)  Dopaminergic synapse
METABOLISM  Enzyme: MAOA [HSA:4128]; CYP3A4 [HSA:1576]
INTERACTION  
STR_MAP     map07057  Antiparkinsonian agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N04 ANTI-PARKINSON DRUGS
               N04B DOPAMINERGIC AGENTS
                N04BD Monoamine oxidase B inhibitors
                 N04BD03 Safinamide
                  D10191  Safinamide mesylate (USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antiparkinson Agents
              Monoamine Oxidase B (MAO-B) Inhibitors
               Safinamide
                D10191  Safinamide mesylate (USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               116  Antiparkinsonian agents
                1169  Others
                 D10191  Safinamide mesylate (USAN); Safinamide mesilate (JAN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01568  MAO inhibitor
               DG01512  Monoamine oxidase B inhibitor
                DG01260  Safinamide
                 D10191  Safinamide mesylate
              DG01967  Antiparkinson agent
               DG01260  Safinamide
                D10191  Safinamide mesylate
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG01260  Safinamide
                 D10191  Safinamide mesylate
              DG02917  MAO substrate
               DG03178  MAOA substrate
                DG01260  Safinamide
                 D10191  Safinamide mesylate
            Drug classes [BR:br08332]
             Neuropsychiatric agent
              DG01967  Antiparkinson agent
               D10191  Safinamide mesylate
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Oxidoreductases (EC1)
               Amine oxidases
                MAOB
                 D10191  Safinamide mesylate (USAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10191
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10191
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10191
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10191
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D10191
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01568  MAO inhibitor
               DG01512  Monoamine oxidase B inhibitor
                DG01260  Safinamide
              DG01967  Antiparkinson agent
               DG01260  Safinamide
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG01260  Safinamide
              DG02917  MAO substrate
               DG03178  MAOA substrate
                DG01260  Safinamide
DBLINKS     CAS: 202825-46-5
            PubChem: 135626909
            LigandBox: D10191
ATOM        27
            1   C8x C     6.0200  -24.5000
            2   C8x C     6.0200  -23.1000
            3   C8x C     7.2100  -22.4000
            4   C8y C     8.4700  -23.1000
            5   C8x C     8.4700  -24.5000
            6   C8y C     7.2100  -25.2000
            7   C1b C     9.6600  -22.4000
            8   O2a O    10.8500  -23.1000
            9   C8y C    12.0400  -22.4000
            10  C8x C    12.0400  -21.0000
            11  C8x C    13.3700  -20.3000
            12  C8y C    14.5600  -21.0000
            13  C8x C    14.5600  -22.4000
            14  C8x C    13.3700  -23.1000
            15  C1b C    15.7500  -20.3000
            16  N1b N    16.9400  -21.0000
            17  C1c C    18.1300  -20.3000
            18  C5a C    19.3200  -21.0000
            19  N1a N    20.5100  -20.3000
            20  O5a O    19.3200  -22.4000
            21  C1a C    18.1300  -18.9000
            22  X   F     7.2100  -26.6000
            23  S4a S    21.9800  -25.1300
            24  O1d O    21.9800  -23.7300
            25  O1d O    21.9800  -26.5300
            26  C1a C    20.5800  -25.1300
            27  O1d O    23.3800  -25.1300
BOND        27
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     4   7 1
            8     7   8 1
            9     8   9 1
            10    9  10 2
            11   10  11 1
            12   11  12 2
            13   12  13 1
            14   13  14 2
            15    9  14 1
            16   12  15 1
            17   15  16 1
            18   16  17 1
            19   17  18 1
            20   18  19 1
            21   18  20 2
            22   17  21 1 #Up
            23    6  22 1
            24   23  24 2
            25   23  25 2
            26   23  26 1
            27   23  27 1
///
